The Netherlands: In the midst of change

  At the World Pharma Pricing & Market Access Congress 2014 conference, Dr Martin van der Graaff, Secretary, Reimbursement Committee, CVZ gave the presentation: “The Netherlands: In the mi(d)st of change” Download and learn: Organisational change in CVZ End of an era: Policy rules and outcomes research First results and experiences with CED Preliminary criteria for prioritizing inpatient drugs Priorities Are …

Netherlands, Anticipate, Future, Pharma, Pharma Pricing

The Netherlands: How to anticipate future pharma and healthcare dynamics?

At the World Pharma Pricing and Market Access Congress 2014, Cornelis Boersma, Head Market Access GSK, gave a presentation “The Netherlands: How to anticipate future pharma and healthcare dynamics?” Boersma’s presentation reflects his attitude “Change towards a predictable and sustainable decision-making system!” Download and learn: Trends in healthcare and pharma expenditures Dutch Pharma system under development NL policy: Implementation of ‘Vuvuzela’ Market Access and …